Xilio Therapeutics
29 hedge funds and large institutions have $48.3M invested in Xilio Therapeutics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 7 closing their positions.
Holders
29
Holders Change
-4
Holders Change %
-12.12%
% of All Funds
0.5%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
3
Increased
3
Reduced
9
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
JPMorgan Chase & Co
New York
| $8K | 2,704 | -31 | -1% |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $6K | 2,069 | -4,086 | -66% |
|
28
UBS Group
Zurich,
Switzerland
| $1K | 201 | -2,613 | -93% |
|
|
DM
29
Deerfield Management
New York
| – | – | -2,078,692 | Closed |
|
|
RCM
30
RA Capital Management
Boston,
Massachusetts
| – | – | -1,649,711 | Closed |
|
31
Norges Bank
Oslo,
Norway
| – | – | -121,887 | Closed |
|
|
B
32
Bailard
Foster City,
California
| – | – | -36,632 | Closed |
|
33
Citigroup
New York
| – | – | -67 | Closed |
|
34
New York State Common Retirement Fund
Albany,
New York
| – | – | -64 | Closed |
|
|
CS
35
Credit Suisse
Zurich,
Switzerland
| – | – | -4 | Closed |
|
|
CFGS
36
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
37
Wells Fargo
San Francisco,
California
| $0 | 75 | +24 | +47% |
|